Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo- controlled extension study (vol 11, pg 425, 2023)

被引：0
|
作者：
Menzies-Gow, A.
Wechsler, M. E.
Brightling, C. E.
机构：
来源：
LANCET RESPIRATORY MEDICINE | 2023年 / 11卷 / 03期
关键词：
D O I：
10.1016/S2213-2600(23)00048-6
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：E25 / E25
页数：1
相关论文
共 50 条
  • [31] Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extension
    Wesson, Donald E.
    Mathur, Vandana
    Tangri, Navdeep
    Stasiv, Yuri
    Parsell, Dawn
    Li, Elizabeth
    Klaerner, Gerrit
    Bushinsky, David A.
    LANCET, 2019, 394 (10196): : 396 - 406
  • [32] Randomised, double-blind, placebo-controlled study to assess long-term effect of dupilumab on prevention of lung function decline (LFD) in patients with uncontrolled moderate-to-severe asthma: ATLAS trial
    Gomez, L. De Prado
    Pavord, I.
    Busse, W.
    Brightling, C. E.
    Wechsler, M. E.
    Rabe, K. F.
    Zhang, M.
    Xing, J.
    Jacob-Nara, J. A.
    Rowe, P. J.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [33] LONG-TERM EFFICACY, TOLERABILITY, AND SAFETY OF NALMEFENE AS-NEEDED IN ALCOHOL-DEPENDENCE: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    van den Brink, W.
    Sorensen, P.
    Torup, L.
    Mann, K.
    Gual, A.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2012, 36 : 247A - 247A
  • [34] Long-term safety of mepolizumab for up to ∼10 years in patients with severe asthma: open-label extension study
    Pavord, Ian
    Chan, Robert
    Brown, Nicola
    Howarth, Peter
    Gilson, Martyn
    Price, Robert G.
    Maspero, Jorge
    ANNALS OF MEDICINE, 2024, 56 (01)
  • [35] A placebo-controlled study of efficacy/safety of aripiprazole intramuscular depot for long-term maintenance treatment of schizophrenia
    Sanchez, R.
    Perry, P.
    Jin, N.
    Johnson, B.
    Forbes, R. A.
    McQuade, R. D.
    Carson, W. H.
    Fleischhacker, W.
    Kane, J. M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S327 - S327
  • [36] Long-term efficacy and safety of bifeprunox in patients with schizophrenia: A 6-month, placebo-controlled study
    Bourin, Michel
    Debelle, Marc
    Heisterberg, Jens
    Josiassen, Mette K.
    Ostergard, Jette B.
    Barbato, Luigi M.
    Yeung, Paul P.
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S187 - S188
  • [37] LONG-TERM PLACEBO-CONTROLLED EFFICACY AND SAFETY STUDY OF ORG-OD-14 IN CLIMACTERIC WOMEN
    BENEDEKJASZMANN, LJ
    MATURITAS, 1987, : 25 - 33
  • [38] Ziprasidone in Adolescents with Schizophrenia: Results from a Placebo-Controlled Efficacy and Long-Term Open-Extension Study
    Findling, Robert L.
    Cavus, Idil
    Pappadopulos, Elizabeth
    Vanderburg, Douglas G.
    Schwartz, Jeffrey H.
    Gundapaneni, Balarama K.
    DelBello, Melissa P.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2013, 23 (08) : 531 - 544
  • [39] Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind, randomised, placebo- controlled trial (vol22, pg 476, 2023)
    Yu, S.
    Kim, B-K
    Guo, A.
    LANCET NEUROLOGY, 2023, 22 (10): : E11 - E11
  • [40] LONG-TERM SAFETY AND EFFICACY OF FITUSIRAN PROPHYLAXIS IN A PHASE 1/2 OPEN-LABEL EXTENSION STUDY IN PEOPLE WITH MODERATE OR SEVERE HEMOPHILIA A OR B
    Pipe, Steven W.
    Lissitchkov, Toshko
    Mangles, Sarah
    Georgiev, Pencho
    Feng, Erin
    Menapace, Laurel A.
    Kichou, Salim
    Andersson, Shauna
    Demissie, Marek
    Ragni, Margaret
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 100 : 99 - 100
12345